German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Surprising Departure: Celgene President and COO "Retiring" in the Summer February 23, 2017 Federal Court Overturns Gilead Sciences and Merck Patent Dispute February 19, 2018 Phoenix Molecular Designs Appoints Leading Oncology Expert As Chief Scientific Officer July 16, 2017